Fidelity International’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $38.6M | Sell |
|
|||||
|
2024
Q2 | $66.5M | Sell |
|
|||||
|
2024
Q1 | $108M | Sell |
|
|||||
|
2023
Q4 | $157M | Buy |
|
|||||
|
2023
Q3 | $105M | Sell |
|
|||||
|
2023
Q2 | $157M | Sell |
|
|||||
|
2023
Q1 | $151M | Sell |
|
|||||
|
2022
Q4 | $165M | Buy |
|
|||||
|
2022
Q3 | $143M | Sell |
|
|||||
|
2022
Q2 | $172M | Buy |
|
|||||
|
2022
Q1 | $228M | Buy |
|
|||||
|
2021
Q4 | $201M | Buy |
|
|||||
|
2021
Q3 | $216M | Buy |
|
|||||
|
2021
Q2 | $188M | Sell |
|
|||||
|
2021
Q1 | $148M | Sell |
|
|||||
|
2020
Q4 | $203M | Buy |
|
|||||
|
2020
Q3 | $168M | Sell |
|
|||||
|
2020
Q2 | $143M | Sell |
|
|||||
|
2020
Q1 | $106M | Sell |
|
|||||
|
2019
Q4 | $130M | Buy |
|
|||||
|
2019
Q3 | $104M | Buy |
|
|||||
|
2019
Q2 | $82.8M | Sell |
|
|||||
|
2019
Q1 | $88.4M | Sell |
|
|||||
|
2018
Q4 | $74.5M | Sell |
|
|||||
|
2018
Q3 | $192M | Sell |
|
|||||
|
2018
Q2 | $196M | Buy |
|
|||||
|
2018
Q1 | $42.6M | Sell |
|
|||||
|
2017
Q4 | $53.5M | Buy |
|
|||||
|
2017
Q3 | $34.5M | Sell |
|
|||||
|
2017
Q2 | $42.2M | Buy |
|
|||||
|
2017
Q1 | $8.83M | Hold |
|
|||||
|
2016
Q4 | $7.48M | Hold |
|
|||||
|
2016
Q3 | $8.18M | Hold |
|
|||||
|
2016
Q2 | $8.09M | Buy |
|
|||||
|
2016
Q1 | $6.57M | Hold |
|
|||||
|
2015
Q4 | $6.95M | Sell |
|
|||||
|
2015
Q3 | $22.4M | Hold |
|
|||||
|
2015
Q2 | $24.9M | Buy |
|
|||||
|
2015
Q1 | $11.6M | Buy |
|